Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts
| Image |  |
|---|---|
| Description | scientific article published on 04 February 2020 |
| Author/s |
author: Tomasz Sacha Daniela Damiani Martin Griesshammer Haifa Kathrin Al-Ali |
| Publication date | February 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |